# Lidocaine Patch 1.8% for Moderate to Severe Pain From Carpal Tunnel Syndrome

> **NCT04245371** · PHASE4 · COMPLETED · sponsor: **John Papakonstantinou, MD** · enrollment: 45 (actual)

## Conditions studied

- Carpal Tunnel Syndrome

## Interventions

- **DRUG:** Lidocaine 1.8%
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04245371
- **Lead sponsor:** John Papakonstantinou, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-02-24
- **Primary completion:** 2023-05-07
- **Final completion:** 2023-05-07
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2023-06-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04245371

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04245371, "Lidocaine Patch 1.8% for Moderate to Severe Pain From Carpal Tunnel Syndrome". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04245371. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*